Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Current Drug Targets in Childhood Acute Leukemia (Guest Editor: R.B. Lock)] promotion: free to download

Volume:8   Issue:6
Pp: 683-683
R. B. Lock
DOI: 10.2174/138945007780830791

Targeting the Leukemia Microenvironment

Volume:8   Issue:6
Pp: 685-701
Marina Konopleva and Michael Andreeff
DOI: 10.2174/138945007780830827

FLT3 as a Therapeutic Target in Childhood Acute Leukemia

Volume:8   Issue:6
Pp: 703-714
Matthew C. Stubbs and Scott A. Armstrong
DOI: 10.2174/138945007780830782

Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia

Volume:8   Issue:6
Pp: 715-725
Christian Flotho, Christian Kratz and Charlotte M. Niemeyer
DOI: 10.2174/138945007780830773

Targeting Transcription Factors in Acute Leukemia in Children

Volume:8   Issue:6
Pp: 727-737
Jason N. Berman and A. Thomas Look
DOI: 10.2174/138945007780830818

The Cytoskeleton as a Therapeutic Target in Childhood Acute Leukemia:Obstacles and Opportunities

Volume:8   Issue:6
Pp: 739-749
Tracy Y. E. Liaw, Melissa H. Y. Chang and Maria Kavallaris
DOI: 10.2174/138945007780830836

Assessing Combinations of Cytotoxic Agents Using Leukemia Cell Lines

Volume:8   Issue:6
Pp: 765-771
C. Patrick Reynolds, Min H. Kang, Nino Keshelava and Barry J. Maurer
DOI: 10.2174/138945007780830845

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing

Volume:8   Issue:6
Pp: 773-783
Petra S. Bachmann and Richard B. Lock
DOI: 10.2174/138945007780830809